Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Personality traits and anxiety affect hair loss patients' quality of life.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Low vitamin D levels are linked to symptoms like muscle cramps, fatigue, and hair loss.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Kerion is a rare but serious scalp infection that needs proper treatment.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Long COVID patients have more health issues than non-infected people.